1. Yang, Qiurong, Wang, Maoye, Xu, Jing, Gu, Jianmei, Zhang, Xu. 2023. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling. In Molecular cancer, 22, 122. doi:10.1186/s12943-023-01814-x. https://pubmed.ncbi.nlm.nih.gov/37537569/
2. Qiao, Lu, Xu, Le, Yu, Lan, Shen, Yufeng, Chung, Wendy K. 2021. Rare and de novo variants in 827 congenital diaphragmatic hernia probands implicate LONP1 as candidate risk gene. In American journal of human genetics, 108, 1964-1980. doi:10.1016/j.ajhg.2021.08.011. https://pubmed.ncbi.nlm.nih.gov/34547244/
3. Jin, Yanan, Yao, Jijin, Fu, Jianchang, Xia, Tianliang, Xia, Liangping. 2024. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA. In Cell death & disease, 15, 578. doi:10.1038/s41419-024-06959-1. https://pubmed.ncbi.nlm.nih.gov/39117671/
4. Nulali, Jiayida, Zhang, Kaiwen, Long, Manmei, Yang, Linhua, Song, Huaidong. 2024. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation. In International journal of biological sciences, 20, 331-346. doi:10.7150/ijbs.82316. https://pubmed.ncbi.nlm.nih.gov/38164181/
5. Jin, Ting, Yang, Liping, Chang, Chao, Dai, Peijin, Liu, Manran. 2024. HnRNPA2B1 ISGylation Regulates m6A-Tagged mRNA Selective Export via ALYREF/NXF1 Complex to Foster Breast Cancer Development. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2307639. doi:10.1002/advs.202307639. https://pubmed.ncbi.nlm.nih.gov/38626369/
6. Yu, Min, Ni, Mengdong, Xu, Fei, Li, Jiajia, Ke, Guihao. 2024. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer. In Molecular cancer, 23, 139. doi:10.1186/s12943-024-02055-2. https://pubmed.ncbi.nlm.nih.gov/38970106/
智鼠故事 
